101 related articles for article (PubMed ID: 18755822)
1. Association between synapsin III gene promoter SNPs and multiple sclerosis in Basque patients.
Otaegui D; Zuriarrain O; Castillo-Triviño T; Aransay A; Ruíz-Martinez J; Olaskoaga J; Marti-Masso J; Lopez de Munain A
Mult Scler; 2009 Jan; 15(1):124-8. PubMed ID: 18755822
[TBL] [Abstract][Full Text] [Related]
2. Association between Synapsin III gene promoter polymorphisms and multiple sclerosis.
Liguori M; Cittadella R; Manna I; Valentino P; La Russa A; Serra P; Trojano M; Messina D; Ruscica F; Andreoli V; Romeo N; Livrea P; Quattrone A
J Neurol; 2004 Feb; 251(2):165-70. PubMed ID: 14991350
[TBL] [Abstract][Full Text] [Related]
3. Genetic association of CASP8 polymorphisms with primary progressive multiple sclerosis.
Camiña-Tato M; Fernández M; Morcillo-Suárez C; Navarro A; Julià E; Edo MC; Montalban X; Comabella M
J Neuroimmunol; 2010 May; 222(1-2):70-5. PubMed ID: 20363033
[TBL] [Abstract][Full Text] [Related]
4. The cannabinoid receptor 1 gene (CNR1) and multiple sclerosis: an association study in two case-control groups from Spain.
Ramil E; Sánchez AJ; González-Pérez P; Rodríguez-Antigüedad A; Gómez-Lozano N; Ortiz P; Arroyo R; De las Heras V; Vilches C; García-Merino A
Mult Scler; 2010 Feb; 16(2):139-46. PubMed ID: 20007426
[TBL] [Abstract][Full Text] [Related]
5. CRYAB promoter polymorphisms: influence on multiple sclerosis susceptibility and clinical presentation.
Stoevring B; Frederiksen JL; Christiansen M
Clin Chim Acta; 2007 Jan; 375(1-2):57-62. PubMed ID: 17010329
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in the promoter region of the alpha1A-adrenoceptor gene are associated with schizophrenia/schizoaffective disorder in a Spanish isolate population.
Clark DA; Arranz MJ; Mata I; Lopéz-Ilundain J; Pérez-Nievas F; Kerwin RW
Biol Psychiatry; 2005 Sep; 58(6):435-9. PubMed ID: 16043131
[TBL] [Abstract][Full Text] [Related]
7. Is tumor necrosis factor-376A promoter polymorphism associated with susceptibility to multiple sclerosis?
Kauffman MA; Morón DG; Sandoval G; Sica RE; Garcea O; Villa AM
Medicina (B Aires); 2007; 67(5):436-8. PubMed ID: 18051225
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetics of MXA SNPs in interferon-beta treated multiple sclerosis patients.
Weinstock-Guttman B; Tamaño-Blanco M; Bhasi K; Zivadinov R; Ramanathan M
J Neuroimmunol; 2007 Jan; 182(1-2):236-9. PubMed ID: 17126411
[TBL] [Abstract][Full Text] [Related]
9. The genetic influence of the nonclassical MHC molecule HLA-G on multiple sclerosis.
Kroner A; Grimm A; Johannssen K; Mäurer M; Wiendl H
Hum Immunol; 2007 May; 68(5):422-5. PubMed ID: 17462509
[TBL] [Abstract][Full Text] [Related]
10. PAI and TPA gene polymorphisms in multiple sclerosis.
Lovrecic L; Ristić S; Starcević-Cizmarević N; Brajenović-Milić B; Jazbec SS; Sepcić J; Kapović M; Peterlin B
Mult Scler; 2008 Mar; 14(2):243-7. PubMed ID: 17986506
[TBL] [Abstract][Full Text] [Related]
11. Increase in CCR5 Delta32/Delta32 genotype in multiple sclerosis.
Pulkkinen K; Luomala M; Kuusisto H; Lehtimäki T; Saarela M; Jalonen TO; Elovaara I
Acta Neurol Scand; 2004 May; 109(5):342-7. PubMed ID: 15080861
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein genotype does not influence MS severity, cognition, or brain atrophy.
van der Walt A; Stankovich J; Bahlo M; Taylor BV; van der Mei IA; Foote SJ; Kilpatrick TJ; Rubio JP; Butzkueven H
Neurology; 2009 Sep; 73(13):1018-25. PubMed ID: 19786693
[TBL] [Abstract][Full Text] [Related]
13. Interleukin 18 receptor 1 expression distinguishes patients with multiple sclerosis.
Gillett A; Thessen Hedreul M; Khademi M; Espinosa A; Beyeen AD; Jagodic M; Kockum I; Harris RA; Olsson T
Mult Scler; 2010 Sep; 16(9):1056-65. PubMed ID: 20354066
[TBL] [Abstract][Full Text] [Related]
14. [Relationship of interleukin-18 gene promoter polymorphisms with chronic hepatitis B in Chinese Han population].
Zhang PA; Wu JM; Li Y; Yang XS
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Oct; 22(5):528-32. PubMed ID: 16215941
[TBL] [Abstract][Full Text] [Related]
15. Haplotype analysis of the preprotachykinin-1 (TAC1) gene in multiple sclerosis.
Cunningham S; Patterson CC; McDonnell G; Hawkins S; Vandenbroeck K
Genes Immun; 2005 May; 6(3):265-70. PubMed ID: 15729363
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms within the tumor necrosis factor-alpha promoter region in patients with HLA-B27-associated uveitis: association with susceptibility and clinical manifestations.
El-Shabrawi Y; Wegscheider BJ; Weger M; Renner W; Posch U; Ulrich S; Ardjomand N; Hermann J
Ophthalmology; 2006 Apr; 113(4):695-700. PubMed ID: 16581430
[TBL] [Abstract][Full Text] [Related]
17. No association between synapsin III gene promoter polymorphisms and multiple sclerosis in German patients.
Akkad DA; Gödde R; Epplen JT
J Neurol; 2006 Oct; 253(10):1365-6. PubMed ID: 16972123
[TBL] [Abstract][Full Text] [Related]
18. The role of the Epstein-Barr virus receptor CD21 in multiple sclerosis.
Toepfner N; Cepok S; Grummel V; Hemmer B
J Neuroimmunol; 2012 Jan; 242(1-2):47-51. PubMed ID: 22137275
[TBL] [Abstract][Full Text] [Related]
19. Interleukin (IL)-1 gene polymorphisms: relevance of disease severity associated alleles with IL-1beta and IL-1ra production in multiple sclerosis.
Schrijver HM; van As J; Crusius JB; Dijkstra CD; Uitdehaag BM
Mediators Inflamm; 2003 Apr; 12(2):89-94. PubMed ID: 12775358
[TBL] [Abstract][Full Text] [Related]
20. Variation in SNPs of the IL7Ra gene is associated with multiple sclerosis in the Iranian population.
Heidari M; Behmanesh M; Sahraian MA
Immunol Invest; 2011; 40(3):279-89. PubMed ID: 21190413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
